Catheters Global Market – Forecast To 2022

1 EXECUTIVE SUMMARY 26

2 INTRODUCTION 30

• 2.1 KEY TAKE AWAYS 30
• 2.2 REPORT DESCRIPTION 30
• 2.3 MARKETS COVERED 32
• 2.4 STAKEHOLDERS 34
• 2.5 RESEARCH METHODOLOGY 34
  • 2.5.1 MARKET SIZE ESTIMATION 36
  • 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 38
  • 2.5.3 SECONDARY SOURCES 39
  • 2.5.4 PRIMARY SOURCES 39
  • 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 40
  • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 41
  • 2.5.7 ASSUMPTIONS 41

3 MARKET ANALYSIS 43

• 3.1 INTRODUCTION 43
• 3.2 MARKET SEGMENTATION 44
• 3.3 FACTORS INFLUENCING MARKET 45
  • 3.3.1 DRIVERS & OPPORTUNITIES 46
    • 3.3.1.1 Increasing life expectancy combined with rise in aging population 46
    • 3.3.1.2 Growing prevalence of cardiovascular diseases, diabetes and urinary diseases 46
    • 3.3.1.3 Growing healthcare budgetary allocation in developing countries 47
    • 3.3.1.4 Trends towards single use catheters and self catheterization 47
    • 3.3.1.5 Emerging economies like india and china catheters market are expected to offer potential opportunities 48
    • 3.3.1.6 Adoption of minimally invasive procedures 49
    • 3.3.1.7 Technological advancements pertaining to catheters materials that prevent biofilm formation 49
  • 3.3.2 RESTRAINTS & THREATS 50
    • 3.3.2.1 Increasing incidences of acquired infections due to biofilm formation during use of long term indwelling catheters 50
    • 3.3.2.2 High cost involved in cardiac and neurological procedures 50
    • 3.3.2.3 Lack of experienced and skilled professional to handle the catheters insertion procedure 51
    • 3.3.2.4 Increase in pricing pressure on market players 51
    • 3.3.2.5 Stringent regulatory bodies 52
• 3.4 REGULATORY AFFAIRS 52
  • 3.4.1 U.S. 52
  • 3.4.2 EUROPE 53
  • 3.4.3 CHINA 54
  • 3.4.4 INDIA 54
  • 3.4.5 JAPAN 55
• 3.5 REIMBURSEMENT SCENARIO 56
  • 3.5.1 REIMBURSEMENT TABLE 56
• 3.6 TECHNOLOGICAL ADVANCEMENTS AND UPCOMING TECHNOLOGIES & PRODUCT LAUNCHES 62
  • 3.6.1 CATHETER BASED IMAGING DEVICES (IMAGING CATHETERS) 63
  • 3.6.2 CATH LAB 63
  • 3.6.3 ROBOTIC CATHETERS 64
  • 3.6.4 3D PRINTED & CUSTOM CATHETERS 64
  • 3.6.5 SPRAY CATHETERS 65
  • 3.6.6 LASER FIBER CATHETERS 65
  • 3.6.7 SINGLE USE REPROCESSED CATHETERS 65
  • 3.6.8 TECHNOLOGIES UNDER CLINICAL TRIAL 66
  • 3.6.9 RECENT AND UPCOMING PRODUCT LAUNCHES 69
• 3.7 COATINGS FOR CATHETERS 74
• 3.8 PORTER’S FIVE FORCE ANALYSIS 75
  • 3.8.1 THREAT OF NEW ENTRANTS 76
  • 3.8.2 THREAT OF SUBSTITUTES 77
  • 3.8.3 RIVALRY AMONG EXISTING COMPETITORS 77
  • 3.8.4 BARGAINING POWER OF SUPPLIERS 77
  • 3.8.5 BARGAINING POWER OF BUYERS 77
• 3.9 SUPPLY CHAIN ANALYSIS 78
• 3.10 PATENT ANALYSIS 79
• 3.11 MARKET SHARE ANALYSIS 81

4 CATHETERS GLOBAL MARKET, BY PRODUCT TYPE 84

• 4.1 INTRODUCTION 84
• 4.2 CARDIAC CATHETERS 86
  • 4.2.1 BALLOON CATHETERS 90
    • 4.2.1.1 Angiography balloon catheters 92
    • 4.2.1.2 Angioplasty balloon catheters 93
    • 4.2.1.2.1 Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters 96
    • 4.2.1.2.2 Percutaneous transluminal angioplasty (PTA) balloon

    catheters 98

    • 4.2.2 ELECTROPHYSIOLOGY CATHETERS 100
      • 4.2.2.1 Diagnostic electrophysiology catheters 103
      • 4.2.2.2 Ablation electrophysiology catheters 105
    • 4.2.3 GUIDING CATHETERS 107
    • 4.2.4 PULMONARY ARTERY CATHETERS 108
    • 4.2.5 INTRAVASCULAR ULTRASOUND CATHETERS 110
  • 4.3 URINARY CATHETERS 112
    • 4.3.1 INTERMITTENT (TEMPORARY OR SHORT-TERM) CATHETERS 115
    • 4.3.2 FOLEY (INDWELLING OR SUPRAPUBIC) CATHETERS 117
    • 4.3.3 MALE EXTERNAL CATHETERS (CONDOM CATHETERS) 119
  • 4.4 NEUROVASCULAR CATHETERS 120
    • 4.4.1 MICRO CATHETERS 124
    • 4.4.2 NEURO THROMBECTOMY CATHETERS 125
    • 4.4.3 NEURO EMBOLIZATION CATHETERS 127
  • 4.5 INTRAVENOUS CATHETERS 128
    • 4.5.1 PERIPHERAL CATHETERS 131
      • 4.5.1.1 Midline peripheral catheters 132
    • 4.5.2 CENTRAL VENOUS CATHETERS 134
      • 4.5.2.1 Peripherally inserted central catheters (PICC) 136
      • 4.5.2.2 Central venous catheter 138
      • 4.5.2.3 Non-tunneled external catheter 139
      • 4.5.2.4 Tunneled external catheter 141
  • 4.6 SPECIALTY CATHETER 143
    • 4.6.1 WOUND/SURGICAL DRAIN CATHETERS 146
    • 4.6.2 OXIMETRY CATHETERS 148
    • 4.6.3 THERMODILUTION CATHETERS 149
    • 4.6.4 DIALYSIS CATHETERS 151
    • 4.6.5 GYNAECOLOGY CATHETERS 152
    • 4.6.6 GASTROENTEROLOGY CATHETER 155

  5 CATHETERS GLOBAL MARKET, BY MATERIALS 157

  • 5.1 INTRODUCTION 157
  • 5.2 CATHETERS MATERIAL COMPARISON 158
  • 5.3 SILICONE CATHETERS 160
  • 5.4 POLYURETHANE CATHETERS 161
  • 5.5 POLYETHYLENE CATHETERS 163
  • 5.6 TEFLON/PTFE CATHETERS 164
  • 5.7 OTHERS (NITINOL, NYLON) CATHETERS 165

  6 CATHETERS GLOBAL MARKET, BY END-USERS 168

  • 6.1 INTRODUCTION 168
  • 6.2 HOSPITALS 170
  • 6.3 AMBULATORY SURGICAL CENTERS 172
  • 6.4 DIAGNOSTIC LABORATORIES 174
  • 6.5 ACADEMIC RESEARCH LABORATORIES 175
  • 6.6 HOME HEALTHCARE PROVIDERS 177

  7 REGIONAL ANALYSIS 179

  • 7.1 INTRODUCTION 179
  • 7.2 NORTH AMERICA 180
  • 7.3 EUROPE 191
  • 7.4 ASIA PACIFIC 202
    • 7.4.1 INDIA 203
    • 7.4.2 CHINA 203
  • 7.5 REST OF THE WORLD 213

  8 COMPANY DEVELOPMENTS 225

  • 8.1 INTRODUCTION 225
  • 8.2 APPROVALS 227
  • 8.3 ACQUISITIONS & COLLABORATIONS 230
  • 8.4 NEW PRODUCT LAUNCHES 233
  • 8.5 AGREEMENTS & EXPANSION 235

  9 COMPANY PROFILES 238

  • 9.1 ABBOTT LABORATORIES 238
    • 9.1.1 OVERVIEW 238
    • 9.1.2 FINANCIALS 239
    • 9.1.3 PRODUCT PORTFOLIO 241
    • 9.1.4 KEY DEVELOPMENTS 242
    • 9.1.5 BUSINESS STRATEGY 243
    • 9.1.6 SWOT ANALYSIS 244
  • 9.2 ANGIODYNAMICS INC. 245
    • 9.2.1 OVERVIEW 245
    • 9.2.2 FINANCIALS 246
    • 9.2.3 PRODUCT PORTFOLIO 248
    • 9.2.4 KEY DEVELOPMENTS 249
    • 9.2.5 BUSINESS STRATEGY 250
    • 9.2.6 SWOT ANALYSIS 251
  • 9.3 B. BRAUN MELSUNGEN AG 252
    • 9.3.1 OVERVIEW 252
    • 9.3.2 FINANCIALS 253
    • 9.3.3 PRODUCT PORTFOLIO 255
    • 9.3.4 KEY DEVELOPMENTS 257
    • 9.3.5 BUSINESS STRATEGY 258
    • 9.3.6 SWOT ANALYSIS 259
  • 9.4 BECTON, DICKINSON AND COMPANY 260
    • 9.4.1 OVERVIEW 260
    • 9.4.2 FINANCIALS 261
    • 9.4.3 PRODUCT PORTFOLIO 263
    • 9.4.4 KEY DEVELOPMENTS 265
    • 9.4.5 BUSINESS STRATEGY 266
    • 9.4.6 SWOT ANALYSIS 267
  • 9.5 BOSTON SCIENTIFIC CORPORATION 268
    • 9.5.1 OVERVIEW 268
    • 9.5.2 FINANCIALS 269
    • 9.5.3 PRODUCT PORTFOLIO 271
    • 9.5.4 KEY DEVELOPMENTS 274
    • 9.5.5 BUSINESS STRATEGY 275
    • 9.5.6 SWOT ANALYSIS 276
  • 9.6 C.R.BARD, INC. 277
    • 9.6.1 OVERVIEW 277
    • 9.6.2 FINANCIALS 278
    • 9.6.3 PRODUCT PORTFOLIO 279
    • 9.6.4 KEY DEVELOPMENTS 281
    • 9.6.5 BUSINESS STRATEGY 282
    • 9.6.6 SWOT ANALYSIS 283
  • 9.7 COLOPLAST 284
    • 9.7.1 OVERVIEW 284
    • 9.7.2 FINANCIALS 285
    • 9.7.3 PRODUCT PORTFOLIO 287
    • 9.7.4 KEY DEVELOPMENTS 288
    • 9.7.5 BUSINESS STRATEGY 288
    • 9.7.6 SWOT ANALYSIS 289
  • 9.8 JOHNSON & JOHNSON 290
    • 9.8.1 OVERVIEW 290
    • 9.8.2 FINANCIALS 291
    • 9.8.3 PRODUCT PORTFOLIO 294
    • 9.8.4 KEY DEVELOPMENTS 296
    • 9.8.5 BUSINESS STRATEGY 296
    • 9.8.6 SWOT ANALYSIS 297
  • 9.9 PHILIPS HEALTHCARE 298
    • 9.9.1 OVERVIEW 298
    • 9.9.2 FINANCIALS 299
    • 9.9.3 PRODUCT PORTFOLIO 302
    • 9.9.4 KEY DEVELOPMENTS 303
    • 9.9.5 BUSINESS STRATEGY 304
    • 9.9.6 SWOT ANALYSIS 305
  • 9.10 ST JUDE MEDICAL, INC 306
    • 9.10.1 OVERVIEW 306
    • 9.10.2 FINANCIALS 307
    • 9.10.3 PRODUCT PORTFOLIO 309
    • 9.10.4 KEY DEVELOPMENTS 311
    • 9.10.5 BUSINESS STRATEGY 313
    • 9.10.6 SWOT ANALYSIS 314
  • 9.11 TELEFLEX INCORPORATED 315
    • 9.11.1 OVERVIEW 315
    • 9.11.2 FINANCIALS 316
    • 9.11.3 PRODUCT PORTFOLIO 318
    • 9.11.4 KEY DEVELOPMENTS 319
    • 9.11.5 BUSINESS STRATEGY 321
    • 9.11.6 SWOT ANALYSIS 321

  LIST OF TABLES

  TABLE 1 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 29

  TABLE 2 CATHETERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE,

  (2014-2022) ($MN) 86

  TABLE 3 CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 89

  TABLE 4 CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 90

  TABLE 5 BALLOON CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 91

  TABLE 6 ANGIOGRAPHY CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 93

  TABLE 7 ANGIOPLASTY CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 95

  TABLE 8 ANGIOPLASTY CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 96

  TABLE 9 PTCA (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY) BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 98

  TABLE 10 PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 99

  TABLE 11 ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 102

  TABLE 12 ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 103

  TABLE 13 DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 104

  TABLE 14 ABLATION ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 106

  TABLE 15 GUIDING CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 108

  TABLE 16 PULMONARY ARTERY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 109

  TABLE 17 INTRAVASCULAR ULTRASOUND CATHETERS GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 111

  TABLE 18 URINARY CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 114

  TABLE 19 URINARY CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 114

  TABLE 20 INTERMITTENT (TEMPERORY) CATHETERS GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 116

  TABLE 21 FOLEY (INDWELLING) CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 118

  TABLE 22 MALE EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 120

  TABLE 23 NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 123

  TABLE 24 NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 123

  TABLE 25 MICRO CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 125

  TABLE 26 NEURO THROMBECTOMY CATHETERS GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 126

  TABLE 27 NEURO EMBOLIZATION CATHETERS GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 127

  TABLE 28 INTRAVENOUS CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 130

  TABLE 29 INTRAVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 130

  TABLE 30 PERIPHERAL CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 133

  TABLE 31 CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 135

  TABLE 32 CENTRAL VENOUS CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 136

  TABLE 33 PICC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 138

  TABLE 34 CVC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 139

  TABLE 35 NON-TUNNELED EXTERNAL CATHETERS GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 141

  TABLE 36 TUNNELED EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 142

  TABLE 37 SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 145

  TABLE 38 SPECIALTY CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 146

  TABLE 39 WOUND/SURGICAL DRAIN CATHETERS GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 147

  TABLE 40 OXIMETRY CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 149

  TABLE 41 THERMODILUTION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 150

  TABLE 42 DIALYSIS CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 152

  TABLE 43 GYNAECOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 155

  TABLE 44 GASTROENTEROLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 156

  TABLE 45 CATHETERS GLOBAL MARKET REVENUE, BY MATERIALS,

  (2014-2022) ($MN) 160

  TABLE 46 SILICONE CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 161

  TABLE 47 POLYURETHANE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 162

  TABLE 48 POLYETHYLENE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 164

  TABLE 49 TEFLON/PTFE CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 165

  TABLE 50 OTHER CATHETERS GLOBAL MARKET REVENUE, BY REGION,

  (2014-2022) ($MN) 167

  TABLE 51 CATHETERS GLOBAL MARKET REVENUE, BY END-USERS,

  (2014-2022) ($MN) 170

  TABLE 52 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 172

  TABLE 53 AMBULATORY SURGICAL CENTRES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 173

  TABLE 54 DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 175

  TABLE 55 ACADEMIC & RESEARCH LABORATORIES GLOBAL MARKET REVENUE,

  BY REGION, (2014-2022) ($MN) 176

  TABLE 56 HOME HEALTHCARE PROVIDERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 178

  TABLE 57 NORTH AMERICAN CATHETERS MARKET REVENUE, BY PRODUCT,

  (2014-2022) ($MN) 183

  TABLE 58 NORTH AMERICAN CARDIOVASCULAR CATHETERS MARKET REVENUE,

  BY TYPE, (2014-2022) ($MN) 184

  TABLE 59 NORTH AMERICAN ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 185

  TABLE 60 NORTH AMERIAN BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 185

  TABLE 61 NORTH AMERICAN ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 186

  TABLE 62 NORTH AMERICAN NEUROVASCULAR CATHETERS MARKET REVENUE,

  BY TYPE, (2014-2022) ($MN) 186

  TABLE 63 NORTH AMERICAN URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 187

  TABLE 64 NORTH AMERICAN INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 187

  TABLE 65 NORTH AMERICAN CENTRAL VENOUS CATHETERS MARKET REVENUE,

  BY TYPE, (2014-2022) ($MN) 188

  TABLE 66 NORTH AMERICAN SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 189

  TABLE 67 NORTH AMERICAN CATHETERS MARKET REVENUE, BY MATERIAL,

  (2014-2022) ($MN) 190

  TABLE 68 NORTH AMERICAN CATHETERS MARKET REVENUE, BY END-USER,

  (2014-2022) ($MN) 191

  TABLE 69 EUROPEAN CATHETERS MARKET REVENUE, BY PRODUCT,

  (2014-2022) ($MN) 194

  TABLE 70 EUROPEAN CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 195

  TABLE 71 EUROPEAN ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 196

  TABLE 72 EUROPEAN BALLOON CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 196

  TABLE 73 EUROPEAN ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 197

  TABLE 74 EUROPEAN NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 197

  TABLE 75 EUROPEAN URINARY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 198

  TABLE 76 EUROPEAN INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 198

  TABLE 77 EUROPEAN CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 199

  TABLE 78 EUROPEAN SPECIALTY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 200

  TABLE 79 EUROPEAN CATHETERS MARKET REVENUE, BY MATERIAL,

  (2014-2022) ($MN) 201

  TABLE 80 EUROPEAN CATHETERS MARKET REVENUE, BY END-USER,

  (2014-2022) ($MN) 202

  TABLE 81 ASIA PACIFIC CATHETERS MARKET REVENUE, BY PRODUCT,

  (2014-2022) ($MN) 205

  TABLE 82 ASIA PACIFIC CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 206

  TABLE 83 ASIA PACIFIC ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE,

  BY TYPE, (2014-2022) ($MN) 207

  TABLE 84 ASIA PACIFIC BALLOON CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 207

  TABLE 85 ASIA PACIFIC ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 208

  TABLE 86 ASIA PACIFIC NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 208

  TABLE 87 ASIA PACIFIC URINARY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 209

  TABLE 88 ASIA PACIFIC INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 209

  TABLE 89 ASIA PACIFIC CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 210

  TABLE 90 ASIA PACIFIC SPECIALTY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 211

  TABLE 91 ASIA PACIFIC CATHETERS MARKET REVENUE, BY MATERIAL,

  (2014-2022) ($MN) 212

  TABLE 92 ASIA PACIFIC CATHETERS MARKET REVENUE, BY END-USER,

  (2014-2022) ($MN) 213

  TABLE 93 ROW CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 216

  TABLE 94 ROW CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 217

  TABLE 95 ROW ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 218

  TABLE 96 ROW BALLOON CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 218

  TABLE 97 ROW ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 219

  TABLE 98 ROW NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 219

  TABLE 99 ROW URINARY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 220

  TABLE 100 ROW INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 220

  TABLE 101 ROW CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 221

  TABLE 102 ROW SPECIALTY CATHETERS MARKET REVENUE, BY TYPE,

  (2014-2022) ($MN) 222

  TABLE 103 ROW CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN) 223

  TABLE 104 ROW CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN) 224

  TABLE 105 APPROVALS (2013-2015) 227

  TABLE 106 ACQUISTIONS & COLLABORATIONS (2013-2015) 230

  TABLE 107 NEW PRODUCT LAUNCHES (2013-2015) 233

  TABLE 108 AGREEMENTS & EXPANSION (2013-2015) 235

  TABLE 109 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES,

  (2013-2015) ($MN) 239

  TABLE 110 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS,

  (2013-2015) ($MN) 240

  TABLE 111 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY,

  (2013-2015) ($MN) 241

  TABLE 112 ANGIODYNAMICS INC.: TOTAL REVENUE AND R&D EXPENSES,

  (2013-2015) ($MN) 246

  TABLE 113 ANGIODYNAMICS INC.: TOTAL REVENUE, BY SEGMENTS,

  (2013-2015) ($MN) 247

  TABLE 114 ANGIODYNAMICS INC.: TOTAL REVENUE, BY GEOGRAPHY,

  (2013-2015) ($MN) 248

  TABLE 115 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES,

  (2012-2014) ($MN) 253

  TABLE 116 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT,

  (2012-2014) ($MN) 254

  TABLE 117 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,

  (2012-2014) ($MN) 255

  TABLE 118 BECTON, DICKINSON AND COMPANY : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 261

  TABLE 119 BECTON, DICKINSON AND COMPANY : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 262

  TABLE 120 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($ MN) 263

  TABLE 121 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 269

  TABLE 122 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-15) ($MN) 270

  TABLE 123 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 271

  TABLE 124 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 278

  TABLE 125 C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 279

  TABLE 126 COLOPLAST: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 285

  TABLE 127 COLOPLAST: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 286

  TABLE 128 COLOPLAST: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 287

  TABLE 129 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 291

  TABLE 130 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS,

  (2013-2015) ($MN) 292

  TABLE 131 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY,

  (2013-2015) ($MN) 293

  TABLE 132 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 299

  TABLE 133 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 300

  TABLE 134 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY,

  (2013-2015) ($MN) 301

  TABLE 135 ST JUDE MEDICAL: TOTAL REVENUE AND R&D EXPENSES,

  (2013-2015) ($MN) 307

  TABLE 136 ST JUDE MEDICAL : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 308

  TABLE 137 ST.JUDE MEDICAL: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 309

  TABLE 138 TELEFLEX INCORPORATED.: TOTAL SALES AND R&D EXPENSES,

  (2013-2015) ($MN) 316

  TABLE 139 TELEFLEX INCORPORATED: TOTAL SALES, BY SEGMENTS,

  (2013-2015) ($MN) 317

  TABLE 140 TELEFLEX INCORPORATED: TOTAL SALES, BY GEOGRAPHY,

  (2013-2015) ($MN) 318

  LIST OF FIGURES

  FIGURE 1 CATHETERS GLOBAL MARKET REVENUE, BY REGION (2014-2022) 28

  FIGURE 2 CATHETERS GLOBAL MARKET: RESEARCH APPROACH 35

  FIGURE 3 CATHETERS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 36

  FIGURE 4 CATHETERS GLOBAL MARKET: FORECASTING MODEL 37

  FIGURE 5 CATHETERS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 38

  FIGURE 6 CATHETER GLOBAL MARKET: MARKET SEGMENTATION 44

  FIGURE 7 MARKET DYNAMICS 45

  FIGURE 8 CATHETERS GLOBAL MARKET: PORTER’S ANALYSIS 76

  FIGURE 9 CATHETERS MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016) 80

  FIGURE 10 CATHETERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 81

  FIGURE 11 CATHETERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE,

  (2015 V’S 2022) ($MN) 85

  FIGURE 12 CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2015 V’S 2022) ($MN) 88

  FIGURE 13 URINARY CATHETERS MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 113

  FIGURE 14 NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE,

  (2015 V’S 2022) ($MN) 122

  FIGURE 15 INTRAVENOUS CATHETER GLOBAL MARKET REVENUE, BY TYPE,

  (2015 V’S 2022) ($MN) 129

  FIGURE 16 SPECIALTY CATHETER GLOBAL MARKET REVENUE, BY TYPE,

  (2015 V’S 2022) ($MN) 144

  FIGURE 17 CATHETER GLOBAL MARKET REVENUE, BY MATERIAL,

  (2015 V’S 2022) ($MN) 159

  FIGURE 18 CATHETER GLOBAL MARKET REVENUE, BY END-USERS,

  (2015 V’S 2022) ($MN) 169

  FIGURE 19 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 180

  FIGURE 20 NORTH AMERICAN CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL, & END-USER OUTLOOK, (2015 V’S 2022) ($MN) 182

  FIGURE 21 EUROPEAN CATHETERS MARKET SIZE, BY PRODUCTS, MATERIALS & END-USER OUTLOOK, (2015 V’S 2022) ($MN) 193

  FIGURE 22 ASIA-PACIFIC CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL & END-USER OUTLOOK, (2015 V’S 2022) ($MN) 204

  FIGURE 23 ROW CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL & END-USER OUTLOOK, (2015 V’S 2022) ($MN) 215

  FIGURE 24 KEY GROWTH STRATEGIES, (2013-2015) 226

  FIGURE 25 SWOT: ABBOTT LABORATORIES 244

  FIGURE 26 SWOT: ANGIODYNAMICS, INC. 251

  FIGURE 27 SWOT: B.BRAUN MELSUNGEN AG 259

  FIGURE 28 SWOT: BECTON DICKINSON & COMPANY 267

  FIGURE 29 SWOT: BOSTON SCIENTIFIC CORPORATION 276

  FIGURE 30 SWOT: C.R.BARD INC. 283

  FIGURE 31 SWOT: COLOPLAST 289

  FIGURE 32 SWOT: JOHNSON & JOHNSON 297

  FIGURE 33 SWOT: PHILIPS HEALTHCARE 305

  FIGURE 34 SWOT: ST.JUDE MEDICAL 314

  FIGURE 35 SWOT: TELEFLEX INCORPORATED 321